Paras Healthcare Borrowings Were Twice Its Pre-Offer Equity

Paras Healthcare Limited entered the offer process with Rs 888.893 crore of total borrowings at June 30, 2026, equal to 2.00 times total equity of Rs 444.96 crore. Non-current borrowings alone equalled 1.03 times equity, while the group’s August 2026 facilities schedule listed only secured borrowings.

How leveraged was Paras Healthcare before the offer?

Paras Healthcare’s pre-offer borrowings were twice its total equity at June 30, 2026. The capitalisation statement reported Rs 888.893 crore of total borrowings and Rs 444.96 crore of total equity, producing the disclosed total-borrowings-to-total-equity ratio of 2.00. Suri & Sudhir, Chartered Accountants, certified the statement on October 14, 2026.

The 2.00 ratio results from total borrowings of Rs 888.893 crore divided by total equity of Rs 444.96 crore. Non-current borrowings of Rs 459.362 crore divided by the same equity balance produced the separately disclosed 1.03 ratio. Current borrowings of Rs 429.531 crore included current maturities of non-current borrowings under the Schedule III definitions used in the capitalisation statement.

Other equity accounted for Rs 434.861 crore of the Rs 444.96 crore equity total, while equity share capital accounted for Rs 10.099 crore. The disclosed leverage ratio therefore depends on both the consolidated borrowing balance and the consolidated equity balance as at June 30, 2026. Post-offer figures were not determinable pending completion of the book-building process and were not included in the statement.

What do the August 2026 secured facilities show?

Paras Healthcare and its subsidiaries had Rs 990.327 crore of aggregate secured facilities outstanding at August 31, 2026, against Rs 1,237.045 crore sanctioned. This August schedule is not directly comparable with the Rs 888.893 crore June 30 capitalisation figure because it includes non-fund-based facilities, such as bank guarantees and letters of credit, alongside fund-based borrowing.

Fund-based facilities, including term loans and working-capital loans, represented Rs 939.467 crore of the Rs 990.327 crore outstanding total at August 31, 2026. Non-fund-based facilities represented the remaining Rs 50.860 crore. Paras Healthcare accounted for Rs 857.236 crore, or about 87% of the August group total, while PHRPL and PMHPL accounted for Rs 53.420 crore and Rs 79.671 crore, respectively.

The June 30 amount is an accounting capitalisation measure divided into current and non-current borrowings. The August 31 amount is a secured-facilities schedule that includes bank guarantees and letters of credit. The two disclosures show the scale and secured structure of group financing, but they do not establish a like-for-like Rs 101.434 crore increase between the two dates.

How were Paras Healthcare’s August facilities structured?

Paras Healthcare’s August 2026 fund-based facilities were concentrated in company-level term loans and working-capital funding, with HDFC Bank the largest named lender. HDFC Bank had Rs 317.783 crore of company term loans outstanding and Rs 287.064 crore of cash-credit or working-capital demand loans outstanding, totalling Rs 604.847 crore of the company’s Rs 827.044 crore fund-based facilities.

Yes Bank had Rs 119.805 crore of company term loans and Rs 68.364 crore of company working-capital funding outstanding as at August 31, 2026. IDFC Bank had Rs 19.835 crore of company term loans and Rs 14.193 crore of working-capital funding. PHRPL had Rs 45.460 crore of Yes Bank term loans, while PMHPL had Rs 60.606 crore of term loans and Rs 6.357 crore of HDFC Bank working-capital funding.

The disclosed interest rate on borrowings typically ranged from 7.75% to 8.75% a year, with each facility generally linked to the relevant lender’s prevailing lending rate. Cash-credit and working-capital demand loans were renewed annually and repayable on demand. Term loans were repayable over periods ranging from 46 to 129.11 months, generally in monthly or quarterly instalments, and typical prepayment penalties were at least 1.00% of the amount repaid.

What secures Paras Healthcare’s facilities and limits its actions?

Paras Healthcare stated that it had no unsecured borrowings as of the red herring prospectus date, and the August 31, 2026 schedule listed secured borrowings for the company and its subsidiaries. Company security typically included first or second pari-passu charges, under which lenders share security at the same priority, over movable fixed assets, current assets, operating cash flows, receivables, revenues, intangibles and goodwill.

The disclosed security included a first pari-passu charge over the Paras Hospital property at Block C-1, Sushant Lok Phase-I, Sector 43, Gurgaon. It also included exclusive charges over specified Udaipur property and the corporate office at Paras Twin Towers-B, Gurugram. Subsidiary security included hypothecation over current and movable fixed assets, Udaipur properties, and an unconditional and irrevocable Paras Healthcare guarantee to Yes Bank for Paras Healthcare (Ranchi) Private Limited.

Facility agreements can require lender approval or intimation for actions including raising additional debt or equity, changing capital structure, creating further charges, entering other borrowing arrangements, expansions, acquisitions and dividend payments. The agreements also list payment defaults, covenant breaches, failure to create or maintain security, insolvency proceedings and failure to maintain a fixed-asset-cover ratio as events of default. Banks confirmed that there had been no current or past loan-term violations, repayment defaults, restructuring, rollover or acceleration event up to the stated date.

Conclusion

Paras Healthcare’s June 30, 2026 capital structure showed Rs 888.893 crore of borrowings against Rs 444.96 crore of equity, producing the disclosed 2.00 total-borrowings-to-equity ratio. The August 31, 2026 schedule showed Rs 990.327 crore of secured facilities outstanding across the group, but its Rs 50.860 crore of non-fund-based facilities makes it broader than the June capitalisation measure.

The next disclosed item to watch is post-offer capitalisation, which was unavailable pending completion of the book-building process. The continuing relevance of the 2.00 ratio will depend on the final offer outcome, later borrowing balances and compliance with facility terms governing additional financing, security creation, expansions and dividends.